
View larger version (39K):
[in a new window]
|
Fig. 7. Sarcoglycans and signaling. (A) Schematics of sarcolemma scaffolding in normal and SG/ muscle cells. Filamin normally associates with sarcoglycans, but in SG/ cells, sarcolemma filamin expression is considerably increased (Thompson et al., 2000 ). A relationship between cytoskeletal stresses and signaling via phosphorylation is posited. DG, dystroglycan; ECM, extracellular matrix; SG, sarcoglycan. The integrin adhesion complex proteins talin, paxillin, vinculin, etc., may be perturbed by the filamin over-expression, affecting signalling. (B) Proposed signaling circuit that incorporates changes in phosphorylation in SG/ tissue (+ or in red) as well as our in vitro results for contractility and viability. Filamin-B overexpression has been shown to accelerate myotube differentiation (van der Flier et al., 2002 ) and is also known to influence MAP-kinase signaling (Awata et al., 2001 ), extending perhaps to ERK-1/2. Filamin also interacts with cvHSP, a homolog of hsp27 (Krief et al., 1999 ) and (P)-hsp27 is a substrate of (P)-MAPKAPK2 (Ibitayo et al., 1999 ), which is in turn a substrate of (P)-p38 MAPK (Ryder et al., 2000 ). Both (P)-hsp27 and (P)-MYPT1/2 are associated with sustained muscle contraction (Ibitayo et al., 1999 ; Sward et al., 2000 ). (P)-ERK-1/2 phosphorylates FAK (Carragher et al., 2003 ). Both (P)-FAK (Laprise et al., 2002 ) and (P)-ERK-1/2 have been linked to myocyte apoptosis (Cheung and Slack, 2004 ; Subramaniam et al., 2004 ). Dashed lines indicate proposed connections, thick lines indicate stretch-induced signals.
|